HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition
TUCSON, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing...
Staff
ORYZON Enters Cooperative Research and Development Agreement (CRADA) with U.S. National Cancer Institute to Develop Iadademstat in Different Cancers
Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology patients with different hematological and...
Frontera Therapeutics Completes $160 Million Series B Financing to Fund Clinical Development and Manufacturing Capabilities
FDA clears Investigational New Drug (IND) application for lead gene therapy product candidate, FT-001, for the treatment of a rare...
Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)
CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to Placebo in Quickly Reducing Agitation...
Integra LifeSciences Appoints Renee Lo as Director
Renee Lo Appointed to Integra Board of DirectorsPRINCETON, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART),...
Cognition Therapeutics Presenting New Analyses from Ongoing Clinical Trial of CT1812 in Mild-to-Moderate Alzheimer’s Disease
- Analyses Demonstrate CT1812 Impact on Alzheimer’s Disease Processes - NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics,...
CannaNova LLC Announces its Formation; CannaNova will Commercialize Consumer Cannabinoid Consumables Using DepoFilm™ Oral Film Technology
CannaNova Cannabinoid Film Cannabinoid Film (CannaNova)Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) -- CannaNova Cannabinoid Film CannaNova LLC today announced...
VYNE Therapeutics to Present at the B&T Cell-Mediated Autoimmune Disease Drug Development Conference
BRIDGEWATER, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company...
PetVivo Holdings, Inc. Announces Formation of Nonprofit PetVivo Cares To Advance The Health & Well-Being of Companion Animals
MINNEAPOLIS, July 19, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company...
California Air Resources Board (CARB) Recent Amendments to the Airborne Toxic Control Measure for Reefer Transportation Units Favors Reflect Scientific’s Cryogenic Clean Air Reefer’s
OREM, Utah, July 19, 2022 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022
SAN DIEGO, July 19, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science...
Humacyte Announces Presentation of Preclinical Data on the HAV™ in Coronary Artery Bypass Grafting at the Basic Cardiovascular Sciences Scientific Sessions
DURHAM, N.C., July 19, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable...
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease
NEWTON, Mass., July 19, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a biopharmaceutical company...
Catalyst Biosciences Sends Letter to Stockholders
Reiterates the Board’s Commitment to Expeditiously Distributing All of the Company’s Available Cash to Stockholders, Net of Liabilities and Obligations...
LifeMD Announces Continued and Rapid Expansion of Virtual Primary Care To over 200 Conditions
LifeMD’s Virtual Primary Care platform now addresses over 200 conditions with its robust infrastructure of doctors, medical professionals, pharmacies, and...
EssilorLuxottica and Politecnico di Milano launch a partnership for the smart glasses of the future
EssilorLuxottica and Politecnico di Milano launch a partnership for the smart glasses of the future EssilorLuxottica and Politecnico di Milano...
Repligen to Report Second Quarter 2022 Financial Results
Webcast and Conference Call to Be Held Tuesday, August 2, 2022 at 8:30 a.m. EDTWALTHAM, Mass., July 19, 2022 (GLOBE...
Quipt Home Medical to Participate at the 42nd Annual Canaccord Growth Conference on August 8th – 11th
Webcasted Presentation to be Held Thursday August 11thCINCINNATI, July 19, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”)...
CorVel Announces Quarterly Earnings Release Webcast
FORT WORTH, Texas, July 19, 2022 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer Brandon O’Brien,...
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA)
PDUFA target action date is November 26, 2022FDA has stated that it is not currently planning to hold an advisory...